Recruiting

MiniStim PNS

Sponsor:

MiniStim LLC

Code:

NCT04580732

Conditions

Chronic Knee Pain

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MiniStim PNS

Study Details

Brief summary:

This is a prospective, multi-center, randomized, study in which 300 evaluable subjects will be randomized 1:1 to receive active or delayed therapy with Moments PNS. Subjects in the Delayed group will start with therapy at 3-month visit follow up. The primary endpoint is a >50% pain relief at 3-months as measured by the Visual Analog Scale (VAS) without increase in baseline pain medications, with additional measurements assessed at 3, 6, 9, 12, 24, and 36-months.

Conditions

Chronic Knee Pain

Study ID

NCT04580732

Start date

May 5, 2021

Status verified date

Oct, 2023

Completion date

Nov, 2025

Anticipated

Primary completion date

Dec, 2024

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

A. Capable of giving informed consent and willing to follow all study related procedures;

B. Women and men >18 years of age;

C. Baseline VAS score of > 5;

D. History of chronic, function-limiting knee pain of at least three months;

E. Not had recent surgical procedures of the knee within the last three months;

F. ≥50% temporary relief from temporary nerve diagnostics;

G. No evidence of anatomic abnormalities that could jeopardize the placement of the device;

H. Able to operate programmer, recharger, study assessments and provide accurate responses;

I. Appropriate candidate for the implant procedure based on the opinion of investigator.

Exclusion Criteria:

A. An active implantable electronic device regardless of whether stimulation is ON or OFF;

B. Dependency on utilizing wearable or transcutaneous monitoring device (hearing aids, continuous glucose monitors, etc.);

C. Pregnant as confirmed by a urine pregnancy test or plan to become pregnant during study;

D. Subject noted no relief from temporary nerve diagnostics;

E. Inability to achieve appropriate positioning;

F. Inability to understand informed consent and protocol;

G. Conditions requiring recurring MRI evaluation or diathermy procedures;

H. Anatomical restrictions such that device placement is not possible;

I. Have a life expectancy of less than 1-year;

J. Worker's compensation claimants;

K. Based on opinion of investigator any legal concerns that would preclude his/her enrollment in the study or potentially confound results;

L. Deemed unsuitable for enrollment by investigator based on medical history or physical examination.

Study Design

Enrollment

350 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

active comparator: Active

Subjects randomized to the Active group, programming parameters will be set, and therapy will be delivered for a minimum of 2-hours per day for the duration of the study.

placebo comparator: Delayed

The delayed group will begin 2-hour stimulation/day at the 3-Month visit.

Interventions

MiniStim PNS

MiniStim PNS is indicated for pain management in adults who have severe intractable chronic pain of peripheral nerve origin.

Primary outcome measure

  • Rate of Change in Pain Relief: >50% pain relief as measured by Visual Analog Scale [ Time Frame: 3-Months ]
  • Adverse Events [ Time Frame: 3-months ]

Central Contacts and Locations

Locations

Seva Medical

Recruiting

Lewisville, Texas, United States, 75057

Contacts

More Information

Sponsor

MiniStim LLC

Last update posted

Oct 6, 2023

Last verified

Oct, 2023

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by MiniStim LLC on 2023-10-06.